OR WAIT null SECS
© 2023 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
Providing patients with more flexibility in how they choose to participate in trials.
What is eConsent?
Even though it has been around for a number of years now, there are still some who mistake its function and potential. Many studies continue to view eConsent as:
For those with this mindset, eConsent is often treated as a box to check. The truth is, that eConsent can and should be viewed as part of an overall consent management strategy. In this vein, it is an important tool that can help transform the entire consent process from the initial design of the informed consent forms (ICF) through to study close-out.
Moving beyond eConsent alone, or paper consent alone for that matter, to a more holistic consent management approach is a natural progression in the industry’s push toward improving research through the delivery of better patient experiences.
Certainly, the ability for patients to consent remotely is a key principle of the industry’s move toward patient-centered research designs meant to increase access to studies and improve trial experiences for broader more diverse groups of patients.
But it is not just the patients that benefit. Consent management is a key part of human-centered study design, helping to save time for all stakeholders—patients, caregivers, study coordinators, clinicians, translators, etc. This approach can result in better accuracy of all consent data over the course of the study, better regulatory compliance and more transparency for all involved.
Using technologies that automate many of these processes increases efficiency and confidence in the data while decreasing stress levels for all involved.
For example, the consent process can be configured to recognize when the consent has been fully executed and generate a copy immediately to all parties. The fully executed consent, in this way, cannot be lost or accidentally destroyed by the patient. Patients and caregivers can also easily check the electronic form if they have questions, versus querying the study team for easily accessible information.
A comprehensive consent management strategy does what “digitized paper” could never do, providing measurable benefits for all research stakeholders.
As researchers seek to make clinical trials more accessible to all patients and improve their experience, it is critical to seek out solutions that allow patients to participate in the ways they want. Remote approaches help patients do more from home, but it should go further. Employing a robust consent management system allows patients to consent remotely, but also gives them more transparency into the consent process—ensuring they always have access to the most up-to-date consents. Sites and other study leaders benefit as well, gaining better visibility into the consent process, more flexibility into how and where they can consent patients, and complete confidence in the audit trail.
Brian Ongioni, VP, Product, ClinOne